<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05087420</url>
  </required_header>
  <id_info>
    <org_study_id>MIGinPOL2021</org_study_id>
    <nct_id>NCT05087420</nct_id>
  </id_info>
  <brief_title>Migraine in Poland - a Web-based Cross-sectional Survey</brief_title>
  <acronym>MIGinPOL2021</acronym>
  <official_title>Migraine in Poland - a Web-based Cross-sectional Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiat Zdrowia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wroclaw Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiat Zdrowia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A survey of Polish respondents will aim to define migraine characteristics in Polish&#xD;
      subjects. To achieve this, a structured questionnaire based mainly on American Migraine&#xD;
      Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The&#xD;
      obtained data should allow for defining disease parameters, burden and received treatments.&#xD;
      Additionally questions regarding patients rhinological symptoms and COVID-19-related history&#xD;
      were included.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Headache phenotype</measure>
    <time_frame>in the preceding year</time_frame>
    <description>Classification of reported headache according to International Classification of Headache Disorders</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Migraine burden</measure>
    <time_frame>in the preceding year</time_frame>
    <description>Consequences of the disease measured by the Migraine Disability Assessment Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Monthly headache days</measure>
    <time_frame>in the preceding month</time_frame>
    <description>Number of days per month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monthly headache days</measure>
    <time_frame>in the preceding year</time_frame>
    <description>Number of days per year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from last headache professional consultation</measure>
    <time_frame>in the preceding 10 years</time_frame>
    <description>Number of months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migraine diagnosed by headache professional</measure>
    <time_frame>in the preceding 10 years</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age at diagnosis</measure>
    <time_frame>from the onset of headache (time frame up to 99 years)</time_frame>
    <description>years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comoribidities</measure>
    <time_frame>in the preceding year</time_frame>
    <description>Disease according to International Classsification of Disease 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of previous headache professional consultation</measure>
    <time_frame>in the preceding 10 years</time_frame>
    <description>Name of headache profession/speciality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of consultations in the last year</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Number 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of consultations in the last year because of headaches</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Number 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days spent in hospital in the last year because of headaches</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Number 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute treatment used</measure>
    <time_frame>in the preceding 10 years</time_frame>
    <description>Name of abortive medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preventive treatment used</measure>
    <time_frame>in the preceding 10 years</time_frame>
    <description>Name of abortive medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute treatment frequency</measure>
    <time_frame>in the last 3 months</time_frame>
    <description>Number of days per month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preventive treatment frequency</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Number of months form the last dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preventive treatment effectiveness</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Employment</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Type of employment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent at work</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Number of hours per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work absence due to headache</measure>
    <time_frame>in the last month</time_frame>
    <description>Number of days per month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presenteeism</measure>
    <time_frame>in the last month</time_frame>
    <description>Number of days per month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PHQ-9 Patient Health Questionnaire</measure>
    <time_frame>in the last 2 weeks</time_frame>
    <description>Number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sinus headache</measure>
    <time_frame>in the last 3 months</time_frame>
    <description>Number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sinonasal symptoms accompanying headache</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Type of symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sinonasal symptoms not associated with headache</measure>
    <time_frame>in the last 12 months</time_frame>
    <description>Type of symptom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID-19 association with headache</measure>
    <time_frame>in the last 2 years</time_frame>
    <description>Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID-19 vaccine association with headache</measure>
    <time_frame>in the last year</time_frame>
    <description>Likert scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Migraine</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participant will be recruited from miscellaneous sources including: specialist headache&#xD;
        practices, primary care clinics, patients associations. An invitation would be also&#xD;
        extended via social and traditional media and employers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  responses missing in questionnaire&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Marta Waliszewska-Prosół, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Departament of Neurolog, Wrocław Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcin Straburzyński, MD, PhD</last_name>
    <phone>+48896211508</phone>
    <email>marcinstraburzynski@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Waliszewska-Prosół, MD, PhD</last_name>
    <email>marta.waliszewska@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marcin Straburzyński</name>
      <address>
        <city>Dzwierzuty</city>
        <state>Warmińsko-mazurskie</state>
        <zip>12-120</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcin Straburzyński, MD, PhD</last_name>
      <phone>604797385</phone>
      <email>marcinstraburzynski@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Wrocław Medical University</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Waliszewska-Prosół, MD, PhD</last_name>
      <email>marta.waliszewska@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>https://forms.gle/dFY8noGSFHxLSNTR6</url>
    <description>Questionnaire link</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 19, 2021</study_first_submitted>
  <study_first_submitted_qc>October 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiat Zdrowia</investigator_affiliation>
    <investigator_full_name>Marcin Straburzynski</investigator_full_name>
    <investigator_title>General practitioner</investigator_title>
  </responsible_party>
  <keyword>migraine</keyword>
  <keyword>headache</keyword>
  <keyword>rhinosinusitis</keyword>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

